ArticleCrohn's & colitis 3602022

Indicators of Suboptimal Treatment and Associated Healthcare Costs Among Patients With Crohn's Disease Initiated on Biologic or Conventional Agents.

Dominic Pilon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.